
 Open Residency
 Open Residency Joel Kocher - This $200M CEO Discovered What Cardiologists Won't Tell You
 Oct 29, 2025 
 In a captivating discussion, Joel Kocher, a seasoned entrepreneur and CEO of Humann, shares insights from his journey in redefining cardiovascular health with a focus on nitric oxide, which he dubs the 'miracle molecule.' He challenges common misconceptions about heart health and emphasizes the importance of thorough clinical trials. Joel also reflects on leadership lessons gained from icons like Michael Dell and Steve Jobs, advocating for adaptability and team growth as cornerstones of success. His vision for Humann positions it as a leading brand in cardiovascular wellness. 
 AI Snips 
 Chapters 
 Books 
 Transcript 
 Episode notes 
Arterial Age Can Differ From Chronological Age
- Joel Kocher measures arterial age separately from chronological age and claims his arterial age is in his low 40s at 70 years old.
- He attributes this to targeted cardiovascular interventions that restore nitric oxide and sustain energy and endurance.
Nitric Oxide Is Central To Vascular Health
- Nitric oxide is a short-lived gas produced by blood vessel linings that signals dilation and keeps vessel linings smooth.
- It serves as a foundational molecule for cardiovascular function beyond just the heart, affecting 60,000 miles of vessels.
Discovery Through A University Presentation
- Joel discovered nitric oxide at a University of Texas investor presentation that hired a Nobel laureate to study cardiovascular health.
- That research sparked his move to commercialize university tech and build Humann around nitric oxide precursors.





